s6y
Company name or ticker
Search
4D Molecular Therapeutics, Inc.
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
Filed
Tuesday, June 21, 2022
Accession number
0000921895-22-002049
Documents
AMENDMENT NO. 1 TO SCHEDULE 13G
SC 13G/A
On sec.gov
Filing index
All files
Complete submission text
SGML header